Citation Impact
Citing Papers
Human mesenchymal stem cells isolated from bone marrow and lymphoid organs support tumor B-cell growth: role of stromal cells in follicular lymphoma pathogenesis
2006
IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function
2016
Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
2002 Standout
Harnessing the Fcμ Receptor for Potent and Selective Cytotoxic Therapy of Chronic Lymphocytic Leukemia
2014
AID−/−μs−/− Mice Are Agammaglobulinemic and Fail to Maintain B220−CD138+ Plasma Cells
2007 StandoutNobel
Multifaceted roles of GSK-3 and Wnt/β-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention
2013
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
2009 Standout
Mechanisms, regulation and functions of the unfolded protein response
2020 Standout
The biology of human natural killer-cell subsets
2001 Standout
CXCR3 and Its Ligand CXCL10 Are Expressed by Inflammatory Cells Infiltrating Lung Allografts and Mediate Chemotaxis of T Cells at Sites of Rejection
2001
Sequential Waves of Functionally Related Proteins Are Expressed When B Cells Prepare for Antibody Secretion
2003
Differential role of CD80 and CD86 on alveolar macrophages in the presentation of allergen to T lymphocytes in asthma
2001
IL-15: targeting CD8+T cells for immunotherapy
2005
Too much of a good thing: The role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2
2007
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
Preventing AID, a physiological mutator, from deleterious activation: regulation of the genomic instability that is associated with antibody diversity
2010 StandoutNobel
The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition
2010 Standout
Chronic inflammation and oxidative stress in human carcinogenesis
2007
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Functional interaction of protein kinase CK2 and activating transcription factor 4 (ATF4), a key player in the cellular stress response
2012
Environmental and Health Impacts of Air Pollution: A Review
2020 Standout
NF-κB in cancer: from innocent bystander to major culprit
2002 Standout
Interleukin-15 biology and its therapeutic implications in cancer
2011
Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients.
1997
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
2021 Standout
Reference values for peripheral blood B-lymphocyte subpopulations: a basis for multiparametric immunophenotyping of abnormal lymphocytes
2001
Turning tumour cells into antigen presenting cells: The next step to improve cancer immunotherapy?
2016
Mesenchymal stem cells in health and disease
2008 Standout
Phase I study of the anti-CD40 humanized monoclonal antibody lucatumumab (HCD122) in relapsed chronic lymphocytic leukemia
2012
Role of AID in Tumorigenesis
2007 StandoutNobel
New insights into role of microenvironment in multiple myeloma
2000
Distinct Populations of Cancer Stem Cells Determine Tumor Growth and Metastatic Activity in Human Pancreatic Cancer
2007 Standout
Human lymphoblastoid cells produce extracellular matrix-degrading enzymes and induce endothelial cell proliferation, migration, morphogenesis, and angiogenesis
1998
Inflammation and cancer: How hot is the link?
2006
PTEN posttranslational inactivation and hyperactivation of the PI3K/Akt pathway sustain primary T cell leukemia viability
2008
Angiogenesis in health and disease
2003 Standout
Sarcoidosis
2013 Standout
Synthetic Double-Stranded RNAs Are Adjuvants for the Induction of T Helper 1 and Humoral Immune Responses to Human Papillomavirus in Rhesus Macaques
2009 StandoutNobel
Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
2018 Standout
Glycogen synthase kinase 3β inhibitors prevent hepatitis C virus release/assembly through perturbation of lipid metabolism
2017 StandoutNobel
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Inflammation and cancer: back to Virchow?
2001 Standout
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
2017 Standout
Vaccination with tumor cells expressing IL-15 and IL-15Rα inhibits murine breast and prostate cancer
2014 StandoutNobel
Gene Expression Profiling Identifies MMP-12 and ADAMDEC1 as Potential Pathogenic Mediators of Pulmonary Sarcoidosis
2009
Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia
2000 Standout
Heavy Metal Toxicity and the Environment
2012 Standout
Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases
2008 Standout
ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical Outcome
2007 Standout
The functions and regulation of the PTEN tumour suppressor
2012 Standout
The AID Dilemma
2012 StandoutNobel
The Mitochondrial Effects of Small Organic Ligands of BCL-2
2006
Cancer-related inflammation
2008 StandoutNature
The chemokine receptor CXCR3 is expressed on malignant B cells and mediates chemotaxis
1999
Genetic dissection of innate immunity to infection: the mouse cytomegalovirus model
2004 StandoutNobel
Functional Roles of the IgM Fc Receptor in the Immune System
2019 StandoutNobel
Evidence of an immunologic mechanism behind the therapeutical effects of arsenic trioxide (As2O3) on myeloma cells
2001
The integrated stress response
2016 Standout
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
Trends in survival of patients with Burkitt lymphoma/leukemia in the USA: an analysis of 3691 cases
2013
Roles of N-Linked Glycans in the Endoplasmic Reticulum
2004 Standout
GSK-3 as potential target for therapeutic intervention in cancer
2014
The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells
2005 Standout
The clinical significance of tumor necrosis factor-α plasma level in patients having chronic lymphocytic leukemia
2002
Augmented IL-15Rα Expression by CD40 Activation Is Critical in Synergistic CD8 T Cell-Mediated Antitumor Activity of Anti-CD40 Antibody with IL-15 in TRAMP-C2 Tumors in Mice
2012 StandoutNobel
Sarcoidosis is a Th1/Th17 multisystem disorder
2010
Interleukin 15: biology and relevance to human disease
2001
CCL25 mediates migration, invasion and matrix metalloproteinase expression by breast cancer cells in a CCR9-dependent fashion
2011
International Union of Pharmacology. XXII. Nomenclature for Chemokine Receptors
2000 Standout
Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells
2002 StandoutNobel
Modulation of NF-κB Activity and Apoptosis in Chronic Lymphocytic Leukemia B Cells
2000
CpG Motifs in Bacterial DNA and Their Immune Effects
2002 Standout
The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation
2011 StandoutScience
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
2016 Standout
Identification of Pancreatic Cancer Stem Cells
2007 Standout
Ig V Gene Mutation Status and CD38 Expression As Novel Prognostic Indicators in Chronic Lymphocytic Leukemia
1999 Standout
Ipilimumab-Induced Sarcoidosis in a Patient With Metastatic Melanoma Undergoing Complete Remission
2011
The ATP‐Binding Site of Protein Kinase CK2 Holds a Positive Electrostatic Area and Conserved Water Molecules
2007
Characterization of clonogenic multiple myeloma cells
2003
Unmutated Ig VH Genes Are Associated With a More Aggressive Form of Chronic Lymphocytic Leukemia
1999 Standout
B-Cell Chronic Lymphocytic Leukemia: A Bird of a Different Feather
1999
The Halogen Bond
2016 Standout
CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment
2005
Human cytokines suppress apoptosis of leukaemic CD5+ B cells and preserve expression of bcl‐2
1997
Accumulation of B Lymphocytes with a Naive, Resting Phenotype in a Subset of Hepatitis C Patients
2003 StandoutNobel
Blimp-1 Orchestrates Plasma Cell Differentiation by Extinguishing the Mature B Cell Gene Expression Program
2002
IL-15: targeting CD8+ T cells for immunotherapy
2005
Biology of Cachexia
1997
Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells
2000
Cancer treatment and survivorship statistics, 2014
2014 Standout
Works of Fausto Adami being referenced
Protein Kinase CK2 Protects Multiple Myeloma Cells from ER Stress–Induced Apoptosis and from the Cytotoxic Effect of HSP90 Inhibition through Regulation of the Unfolded Protein Response
2012
Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell death
2010
Multiple myeloma plasma cells show different chemokine receptor profiles at sites of disease activity
2007
Intensive short‐term chemotherapy regimen induces high remission rate (over 90%) and event‐free survival both in children and adult patients with advanced sporadic Burkitt lymphoma/leukemia
2011
Serum levels of tumour necrosis factor-α in patients with B-cell chronic lymphocytic leukaemia
1994
B lymphocytes from patients with chronic lymphoproliferative disorders are equipped with different costimulatory molecules.
1997
Expression and functional role of the p75 interleukin 2 receptor chain on leukemic hairy cells.
1992
Tumor necrosis factor-alpha and B-cell growth factor induce leukemic hairy cells to proliferate in vitro.
1991
CD138/syndecan-1: a useful immunohistochemical marker of normal and neoplastic plasma cells on routine trephine bone marrow biopsies.
1999
Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomas
2004
B7 costimulatory molecules from malignant cells in patients with B-cell chronic lymphoproliferative disorders trigger T-cell proliferation
2000
Multiple myeloma cell survival relies on high activity of protein kinase CK2
2006
Expression and regulation of tumor necrosis factor, interleukin-2, and hematopoietic growth factor receptors in B-cell chronic lymphocytic leukemia
1994
Human myeloma cells express the CD38 ligand CD31
1999
Interleukin-15 promotes the growth of leukemic cells of patients with B- cell chronic lymphoproliferative disorders
1996
Regulation of alveolar macrophage-T cell interactions during Th1-type sarcoid inflammatory process
1999